AstraZeneca teams up with startup Quell in type 1 diabetes, IBD cell therapy pact
Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
*please scroll down for all the latest news*
Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
*please scroll down for all the latest news*